Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

Literature DB >> 30328563

The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

Werner B F Brouwer^1,2,3.

Abstract

Mesh：

Year: 2019 PMID： 30328563 DOI： 10.1007/s40273-018-0730-6

Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981

× No keyword cloud information.

21 in total

Review 1. How much will Herceptin really cost?

Authors: Ann Barrett; Tom Roques; Matthew Small; Richard D Smith
Journal: BMJ Date: 2006-11-25

2. Implications of spillover effects within the family for medical cost-effectiveness analysis.

Authors: Anirban Basu; David Meltzer
Journal: J Health Econ Date: 2005-04-22 Impact factor: 3.883

3. How to include informal care in economic evaluations.

Authors: Renske J Hoefman; Job van Exel; Werner Brouwer
Journal: Pharmacoeconomics Date: 2013-12 Impact factor: 4.981

4. Measuring health and well-being effects in family caregivers of children with craniofacial malformations.

Authors: Nalin Payakachat; J Mick Tilford; Werner Bf Brouwer; N Job van Exel; Scott D Grosse
Journal: Qual Life Res Date: 2011-02-24 Impact factor: 4.147

5. Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Authors: Christopher McCabe
Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981

6. Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

Authors: Pieter van Baal; David Meltzer; Werner Brouwer
Journal: Pharmacoeconomics Date: 2013-05 Impact factor: 4.981

7. Informal care and caregiver's health.

Authors: Young Kyung Do; Edward C Norton; Sally C Stearns; Courtney Harold Van Houtven
Journal: Health Econ Date: 2014-04-17 Impact factor: 3.046

8. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.

Authors: R Schulz; S R Beach
Journal: JAMA Date: 1999-12-15 Impact factor: 56.272

9. Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis: a case for excluding dialysis costs.

Authors: Daniel T Grima; Lisa M Bernard; Elizabeth S Dunn; Philip A McFarlane; David C Mendelssohn
Journal: Pharmacoeconomics Date: 2012-11-01 Impact factor: 4.981

10. Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.

Authors: Hareth Al-Janabi; Job Van Exel; Werner Brouwer; Caroline Trotter; Linda Glennie; Laurie Hannigan; Joanna Coast
Journal: Health Econ Date: 2015-10-14 Impact factor: 3.046

16 in total

1. Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature.

Authors: Eve Wittenberg; Lyndon P James; Lisa A Prosser
Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981

2. Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness.

Authors: Lisa A Prosser; Eve Wittenberg
Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981

3. Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Authors: Christopher McCabe
Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981

4. The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective.

Authors: Rhiannon Tudor Edwards
Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981

5. Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease.

Authors: B Rodríguez-Sánchez; S Daugbjerg; L M Peña-Longobardo; J Oliva-Moreno; I Aranda-Reneo; A Cicchetti; J López-Bastida
Journal: Eur J Health Econ Date: 2022-05-20

6. "It is not a scientific number it is just a feeling": Populating a multi-dimensional end-of-life decision framework using deliberative methods.

Authors: Joanna Coast; Cara Bailey; Alastair Canaway; Philip Kinghorn
Journal: Health Econ Date: 2021-03-01 Impact factor: 2.395

7. Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data.

Authors: Angela Devine; Ayodhia P Pasaribu; Tedlla Teferi; Huong-Thu Pham; Ghulam Rahim Awab; Febrina Contantia; Thuy-Nhien Nguyen; Viet-Thanh Ngo; Tinh-Hien Tran; Asrat Hailu; Kim Gilchrist; Justin A Green; Gavin Ckw Koh; Kamala Thriemer; Walter Rj Taylor; Nicholas Pj Day; Ric N Price; Yoel Lubell
Journal: Bull World Health Organ Date: 2019-09-27 Impact factor: 9.408